DK176081B1 - Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed - Google Patents

Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed Download PDF

Info

Publication number
DK176081B1
DK176081B1 DK199700896A DK89697A DK176081B1 DK 176081 B1 DK176081 B1 DK 176081B1 DK 199700896 A DK199700896 A DK 199700896A DK 89697 A DK89697 A DK 89697A DK 176081 B1 DK176081 B1 DK 176081B1
Authority
DK
Denmark
Prior art keywords
melatonin
drug
patient
benzodiazepine
benzodiazepine drug
Prior art date
Application number
DK199700896A
Other languages
Danish (da)
English (en)
Other versions
DK89697A (da
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of DK89697A publication Critical patent/DK89697A/da
Application granted granted Critical
Publication of DK176081B1 publication Critical patent/DK176081B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK199700896A 1995-02-01 1997-07-30 Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed DK176081B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
US38153595 1995-02-01
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
EP95303853 1995-06-06
IB9600082 1996-01-29
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
DK89697A DK89697A (da) 1997-07-30
DK176081B1 true DK176081B1 (da) 2006-04-18

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199700896A DK176081B1 (da) 1995-02-01 1997-07-30 Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed

Country Status (22)

Country Link
JP (1) JP4516159B2 (lv)
CN (1) CN1083263C (lv)
AT (1) AT408188B (lv)
AU (1) AU695366B2 (lv)
BG (1) BG62876B1 (lv)
BR (1) BR9607169A (lv)
CZ (1) CZ291349B6 (lv)
DK (1) DK176081B1 (lv)
EE (1) EE03384B1 (lv)
FI (1) FI119586B (lv)
IS (1) IS1980B (lv)
LU (1) LU90118B1 (lv)
LV (1) LV11940B (lv)
MD (1) MD1716C2 (lv)
NO (1) NO312814B1 (lv)
NZ (1) NZ298878A (lv)
PL (1) PL183148B1 (lv)
SI (1) SI9620022A (lv)
SK (1) SK284521B6 (lv)
TR (1) TR199700723T1 (lv)
TW (1) TW483757B (lv)
WO (1) WO1996023496A1 (lv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227002B1 (en) 2000-01-05 2010-04-28 Neurim Pharma 1991 Use of melatonin in the manufacture of controlled release medicament for the prevention or treatment of symptoms of hypertension
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
ES2646197T3 (es) 2012-01-26 2017-12-12 Vanda Pharmaceuticals Inc. Tratamiento de trastornos del ritmo circadiano
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
WO2014100292A1 (en) 2012-12-18 2014-06-26 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
CN109922795B (zh) * 2016-10-31 2021-10-08 纽里姆药物有限公司 褪黑素小片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000073I1 (de) * 1991-05-09 2008-01-31 Neurim Pharma 1991 Melatonin enthaltene Arzneimittel
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
JPH10513177A (ja) 1998-12-15
SI9620022A (sl) 1998-10-31
CN1083263C (zh) 2002-04-24
ATA901396A (de) 2001-02-15
PL183148B1 (pl) 2002-05-31
CZ240597A3 (cs) 1998-01-14
SK103097A3 (en) 1998-01-14
JP4516159B2 (ja) 2010-08-04
AU695366B2 (en) 1998-08-13
MX9705856A (es) 1998-07-31
FI119586B (fi) 2009-01-15
NO312814B1 (no) 2002-07-08
EE9700166A (et) 1998-02-16
CN1172431A (zh) 1998-02-04
MD970254A (en) 1999-05-31
IS1980B (is) 2005-01-14
MD1716B2 (en) 2001-08-31
CZ291349B6 (cs) 2003-02-12
LV11940A (lv) 1998-01-20
BR9607169A (pt) 1997-11-11
BG101803A (en) 1998-04-30
AU4457496A (en) 1996-08-21
TR199700723T1 (xx) 1998-02-21
NO973531D0 (no) 1997-07-31
NZ298878A (en) 1999-05-28
EE03384B1 (et) 2001-04-16
PL321630A1 (en) 1997-12-08
FI973185A0 (fi) 1997-07-31
FI973185A (fi) 1997-09-30
TW483757B (en) 2002-04-21
MD1716C2 (ro) 2002-02-28
IS4532A (is) 1997-07-25
BG62876B1 (bg) 2000-10-31
LV11940B (lv) 1998-05-20
DK89697A (da) 1997-07-30
AT408188B (de) 2001-09-25
WO1996023496A1 (en) 1996-08-08
SK284521B6 (sk) 2005-05-05
LU90118B1 (fr) 1997-11-13
NO973531L (no) 1997-09-30

Similar Documents

Publication Publication Date Title
Palagini et al. International expert opinions and recommendations on the use of melatonin in the treatment of insomnia and circadian sleep disturbances in adult neuropsychiatric disorders
Askenasy Sleep disturbances in Parkinsonism
EP0724878B1 (en) Use of melatonin for treating patients suffering from drug dependencies
Khullar The Role of Melatonin in the Circadian Rhythm Sleep-Wake Cycle: A Review of Endogenous and Exogenous Melatonin.
Zisapel Melatonin and sleep
DK176081B1 (da) Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed
Söderpalm et al. Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration
US20050175692A1 (en) Pharmaceutical formulation comprising melatonin
Luboshizsky et al. Sleep-inducing effects of exogenous melatonin administration
Neubauer Current and new thinking in the management of comorbid insomnia
CA2211839C (en) Use of melatonin for treating patients suffering from drug addiction
Yimam et al. Effect of UP165, a Zea mays Leaf Extract Standardized for 6‑methoxybenzoxazolinone, as Sleep Adjunct
Hajak et al. Clinical management of patients with insomnia: the role of zopiclone
Bae et al. Too Much of a Good Thing
MXPA97005856A (en) Use of melatonine in the manufacture of unmedicament to deal with addiction to dro
Mayer Sodium oxybate in the treatment of narcolepsy
Fitzpatrick Melatonin in health and disease
Conroy et al. Sleep and substance use and abuse
Miner et al. Treatment of Sleep-Related Movement and Circadian Rhythm Disorders, Hypersomnolence, and Parasomnias
Lee-Chiong et al. Pharmacologic Therapy of Chronic Insomnia in Older Adults

Legal Events

Date Code Title Description
PUP Patent expired

Expiry date: 20170730